De-escalated Therapy Omitting Anthracyclines for Stage I HER2-positive Breast Cancer: A Retrospective Observational Study

Conclusion: In a real-world setting, de-escalated therapy without anthracyclines demonstrated excellent outcomes similar to the standard therapy containing anthracyclines as well as lower adverse events.

Source: In Vivo - November 3, 2020 Category: Research Authors: NAKAMOTO, S., IKEDA, M., KUBO, S., YAMAMOTO, M., YAMASHITA, T. Tags: Clinical Studies Source Type: research